Convergent development of unique treatment systems for retinal disorders
Convergent development of unique treatment systems for retinal disorders
Oxular’s technologies were developed together to find solutions that would solve significant remaining unmet challenges in retinal care. Together, these systems will transform the treatment of retinal disorders.
Oxuspheres™
Our development products incorporate our proprietary Oxuspheres™ drug-containing, biodegradable polymer system. Oxuspheres are designed to deliver clinically therapeutic drug levels over prescribed treatment periods to the target tissues involved in retinal disorders, while maintaining low drug levels elsewhere in the eye to minimize off-target drug side effects.
Oxusphere drug products provide sustained drug treatments and have the potential to address significant unmet needs by improving patient outcomes and dramatically reducing the unsustainably high treatment burden for patients, retinal specialists, and healthcare systems.
Key features
Safe, biodegradable, sustained-release drug product
Highly tunable to independently adjust dosing and duration
Designed to perform in targeted small spaces in the eye, such as the suprachoroidal space
Well suited for a variety of agents
Low-volume preparations avoid reflux, and significant acute elevations in intraocular pressure following administration
Key benefits
Provides sustained treatment for up to one year following a single administration
Long-lasting treatments significantly reduce the number of annual injections and visits for patients and clinicians
Provides targeted drug distribution to the specific tissues involved in retinal diseases
Sustained therapy translates to more consistent treatment and better adherence
